SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 198.69+2.0%Dec 18 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (13519)1/20/1998 11:59:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
I also expect the merger of AHP with SBH to be a major plus for LGND. AHP has licensed progestin agonosist and antagonist form LGND and they are slated to start TSE424 in the clinic. SBH has been working on small molecules to mimic Epogen. Kevin Wilson emphasized drug discovery and rapid drug development as being very important in today's environment, and as you know, LGND is grossly underfunded and really needs help from tehh big boys. If the merger goes through, they will have two alliances with the biggest boy (at least in terms of pharmaceutical sales).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News